How much does targeted therapy for breast cancer cost

How much does targeted therapy for breast cancer cost?

Targeted treatment for breast cancer also requires the use of other drugs and examinations. The part that medical insurance cannot reimburse also needs to be borne by the patient, which will also affect the cost. At present, the most commonly used targeted treatment drug for breast cancer in clinical practice is HER2 trastuzumab. The cost of targeted treatment for breast cancer is about 20,000 to 30,000 yuan.

What is triple-negative breast cancer?

When all three of these breast cancers are negative, this breast cancer is called triple-negative breast cancer, which has poor treatment effects and progresses rapidly, and most patients will relapse in about a year. This breast cancer is ineffective against endocrine therapy and targeted therapy, so patients lack two treatments, even if chemotherapy has limited effect. Triple-negative breast cancer refers to immunohistochemistry results that are negative for estrogen receptors, negative for HER2 receptors, and negative for progesterone receptors.

How long can you live after chemotherapy for breast cancer?

The prognosis is better in the early stage, and the 5-year survival rate after treatment can reach more than 95%. In the late stage with distant metastasis or other adverse prognostic factors, the 5-year survival rate is 30-40%. When determining how long a breast cancer patient can live after treatment, it is necessary to clarify the tumor's stage payment, molecular phenotype and treatment method, and a professional oncologist should make a comprehensive judgment.

Treatment options include surgery, radiotherapy, chemotherapy, endocrine therapy, targeted therapy, etc. If breast abnormalities occur, timely medical treatment is important for the patient's quality of life and survival.